Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.
Integr Cancer Ther. 2009 Dec;8(4):416-22. doi: 10.1177/1534735409352082.
Integr Cancer Ther. 2009.
PMID: 20042414
Free article.